FLAG (Fludarabine, Cytarabine, G-CSF) as a second line therapy for acute lymphoblastic leukemia with myeloid antigen expression: In vitro and in vivo effects

European Journal of Haematology

Volumn 56, Issue 5, 1996, Pages 308-312

  Visani, Giuseppe ^a,b   Tosi, Patrizia ^a   Zinzani, Pier Luigi ^a   Manfroi, Silvia ^a   Ottaviani, Emanuela ^a   Cenacchi, Annarita ^a   Carrara, Paola ^a   Clavio, Marino ^a   Gobbi, Marco ^a   Tura, Sante ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Acute lymphoblastic leukemia; Antigens; Fludarabine; G CSF; Myeloid

Indexed keywords

CYTARABINE; FLUDARABINE; GLUCOCORTICOID; GRANULOCYTE COLONY STIMULATING FACTOR; MYELOID ANTIGEN; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BLEEDING; BONE MARROW SUPPRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONJUNCTIVITIS; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; MALE; NAUSEA; PHOTOPHOBIA; PRIORITY JOURNAL; SEPSIS; TOPICAL DRUG ADMINISTRATION; VOMITING;

EID: 9344226138     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1996.tb00720.x     Document Type: Article

References (27)

1. CHAMPLIN R, GALE RP. Acute lymphoblastic leukemia: recent advances in biology and therapy. Blood 1989: 73: 2051-2059.
2. WILLEMZE R, PETERS WG, VAN HENNIK MB, et al. Intermediate and high dose Ara-C and m-Amsa (or Daunorubicin) as remission and consolidation treatment for patients with relapsed acute leukemia and lymphoblastic non-Hodgkin lymphoma. Scand J Hematol 1985: 34: 87-94.
3. HIDDEMAN W, KRETZMANN H, STRAIF K, et al. Cytosine Arabinoside in combination with mitoxantrone for the treatment of refractory acute myeloid and lymphoblastic leukemia. Semin Oncol 1987: 14: 87-95.
4. ARLIN ZA, FELDMAN E, KEMPLIN S, et al. Amsacrine with high-dose cytarabine is highly effective therapy for refractory and relapsed acute lymphoblastic leukemia in adults. Blood 1988: 72: 433-439.
5. HIDDEMAN W, BUCHNER TH, HEIL G, et al. Treatment of refractory acute lymphoblastic leukemia in adults with high dose Cytosine Arabinoside and mitoxantrone (HAM). Leukemia 1990: 4: 637-644.
6. KANTARJIAN H, WOLTERS RI, KEATING MJ, et al. Mitoxantrone and high-dose Cytosine Arabinoside for the treatment of refractory acute lymphoblastic leukemia. Cancer 1990: 65: 5-12.
7. GIONA F, TESTI AM, AMADORI S, et al. Idarubicin and high-dose cytarabine in the treatment of refractory and relapsed acute lymphoblastic leukemia. Ann Oncol 1990: 1: 51-57.
8. FREUND N, DIETRICH H, GANSER A, et al. Treatment of relapsed or refractory adult acute lymphoblastic leukemia. Cancer 1992: 709: 69-76.
9. GIONA F, TESTI AM, ANNINO L, et al. Treatment of primary refractory and relapsed acute lymphoblastic leukemia in children and adults: the GIMEMA/AIEOP experience. Br J Haematol 1994: 86: 314-321.
10. HIDDEMAN W, ROTTMAN R, WORMANN B, et al. Treatment of advanced chronic lymphoblastic leukemia by fludarabine: results of a clinical phase II study. Ann Hematol 1991: 63: 1-8.
11. HOCHSTER HS, KIM K, GREEN MD, et al. Activity of fludarabine in previously treated non-Hodgkin's low grade lymphoma: results of an Eastern Cooperative Oncology Study Group. J Clin Oncol 1992: 10: 28-33.
12. GANDHI V, ESTEY E, KEATING MJ, et al. Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy. J Clin Oncol 1993: 11: 116-123.
13. ESTEY E, PLUNKETT W, GANDHI V, et al. Fludarabine and arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukemia. Leuk Lymph 1993: 9: 343-347.
14. TOSI P, VISANI G, OTTAVIANI E, et al. Fludarabine + Ara-C + G-CSF: cytotoxic effect and induction of apoptosis on fresh acute myeloid leukemia cells. Leukemia 1994: 8: 2076-2082.
15. SUKI S, KANTARJIAN H, GANDHI V, et al. Fludarabine and cytosine arabinoside in the treatment of refractory or relapsed acute lymphoblastic leukemia. Cancer 1994: 72: 2155-2160.
16. ESTEY E, THALL P, ANDREEFF M, et al. Use of G-CSF before, during and after Fludarabine+Ara-C induction therapy of newly-diagnosed AML or MDS: comparison with Fludarabine+Ara-C without G-CSF. J Clin Oncol 1994: 4: 671-678.
17. VISANI G, TOSI P, ZINZANI PL, et al. FLAG (Fludarabine+High dose Cytarabine+G-CSF): an effective and tolerable protocol for the treatment of 'poor risk' acute myeloid leukemias. Leukemia 1994: 8: 1842-1846.
18. BACCARANI M, CORBELLI G, AMADORI S, et al. Adolescent and adult acute lymphoblastic leukemia: prognostic features and outcome of therapy. A study of 293 patients. Blood 1982: 63: 677-684.
19. PONDE CK, CHONDURI K, NEOGY K, et al. Characterization of DNA binding protein released from S180 chromatin during brief digestion with DNAse I. Mol Cell Biochem 1987: 101-108.
20. HUANG P, CHUBB S, PLUNKETT W, et al. Incorporation of 9-b-arabinofuranosyl-2-fluoroadenine into DNA and its chain termination: effect on DNA synthesis. J Biol Chem 1990: 265: 11617-11623.
21. CUNEO A, DEMUYNCK H, LOUWAGIE A, et al. Minor myeloid component in Ph chromosome-positive acute lymphoblastic leukemia: correlation with cytogenetic pattern and implication for poor response to therapy. Br J Haematol 1994: 515-521.
22. ZINZANI PL, TOSI P, VISANI G, et al. Apoptosis induction with three nucleoside analogs on Freshly isolated B-chronic lymphocytic leukemia cells. Am J Hematol 1994: 49: 301-306.
23. WIERSMA SR, ORTEGA J, SOBEL E, et al. Clinical importance of myeloid-antigens expression in acute lymphoblastic leukemia of childhood. N Engl J Med 1991: 324: 800-806.
24. DREXLER HG, THIEL E, LUDWIG WD, et al. Review of incidence and clinical relevance of myeloid antigens-positive acute lymphoblastic leukemia. Leukemia 1991: 5: 637-642.
25. KOMADA Y, ZHOU Y-W, ZHANG S-L, et al. Role in growth regulation of cytokines and cytokine receptors in acute lymphoblastic leukemia expressing myeloid markers. Br J Haematol 1993: 84: 408-413.
26. TSUCHIYA H, ASOU N, WATANABE M, et al. Myeloid-antigens expression in childhood acute lymphoblastic leukemia. N Engl J Med 1991: 325: 1380-1381.
27. TSUCHIYA H, ADACHI N, ASOU N, et al. Responses to granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage CSF in Phi-positive acute lymphoblastic leukemia with myeloid surface markers. Blood 1991: 77:411-417.